Perstorp Ab

Other

Matti Siren

Lars Edvinsson

Lars Perrson

Bertil Lofkvist

David Blake

Use of an ester of inositoltrisphosphate for the preparing of medicaments

A pharmaceutical composition comprising a pharmaceutically active ingredient selected from the group consisting of trisphosphorylated pentoses, pentitols or anhydropentitols, trisphosphorylated hexoses, hexitols or anhydrohexitols and trisphosphorylated heptoses, heptitols or anhydroheptitols. The active ingredient can also be present in the form of a salt. The invention also includes a method of preventing or alleviating tissue damage in mammals, including man. The method comprises administering an effective amount of the pharmaceutical composition.

Pharmaceutical composition

Use of mono and di inositolphosphates for treating inflammation

A method of preventing or alleviating renal disorders by administering to a human or an animal in need thereof a pharmaceutical composition comprising an effective amount amount of at least one specific isomer of inositol trisphosphate sufficient to obtain said prevention or alleviation.

Method of treating renal disorders with inositoltriphosphate

Use of inositoltrisphosphate to treat abnornal gastrointestinal motility

New derivatives of cyclohexane in substantially pure form suitable as pharmaceutical, foodstuff or as a stabilizer.

Derivatives of cyclohexane

New derivatives of cyclohexane in substantially pure form suitable as a pharmaceutical, foodstuff or as a stabilizer.

Esters of myo-inositol phosphate

A method of reducing the negative effect of cadmium or aluminum ion or free-radicals in body tissues and a method of alleviating cardiovascular diseases and conditions by administering to a human or an animal a pharmaceutical composition comprising an amount of at least one specific isomer of inositol triphosphate sufficient to obtain said alleviation.

Method of treating cardiovascular diseases

A method of preventing or alleviating certain conditions by administering to a human or an animal a pharmaceutical composition comprising an amount of at least one specific isomer of inositol trisphosphate sufficient to obtain said prevention or alleviation.

Method of treating cardiovascular diseases using inositoltrisphosphate

A method of preventing or alleviating tissue or bone damage in mammals is disclosed. The method comprises administering, to a mammal, a tissue damage or a bone damage preventing or alleviating effective amount of a pharmaceutical composition which includes at least one isomer of inositol trisphosphate.

Method of alleviating bone damage with inositoltriphosphate

A method of reducing the negative effects of heavy metals and a method of preventing or alleviating immunodeficiency, hypertension and dermatitis in mammals is disclosed. In these methods pharmaceutical compositions are administered to a mammal in need thereof. The particular pharmaceutical composition includes a reducing, preventing or alleviating effective amount, for the particular condition, of at least one isomer of inositol triphosphate.

A method of achieving an immunosuppressive effect

A method of treating diabetes or complications of diabetes is disclosed. In this method a pharmaceutically effective amount of at least one isomer of inositol triphosphate is administered to a human or an animal in need thereof.

Method of treating diabetes with inositol triphosphate

A method of reducing the negative effect of cadmium or aluminum ion or free-radicals in body tissues and a method of preventing or alleviating certain diseases and conditions by administering to a human or an animal a pharmaceutical composition comprising an amount of at least one specific isomer of inositol triphosphate sufficient to obtain said prevention or alleviation.

Growing community of inventors

Montagnola/Lugano, Switzerland

Matti Siren